Related Experiment Video
Updated: Jan 9, 2026
08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
21.9K
Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia
Binsah George1, Manu Pandey2, Jacob Herstein3
1Department of Hematology-Oncology, University of Texas Health Science Center at Houston.
American Journal of Clinical Oncology
|December 3, 2025
Summary
Natural killer (NK) cells show promise in fighting acute myeloid leukemia (AML) by enhancing the immune system. Research explores harnessing NK cell therapy to overcome treatment resistance and improve patient outcomes in AML.
Area of Science:
- Hematologic Oncology
- Immunology
- Innate Immunity
Background:
- Acute myeloid leukemia (AML) presents significant challenges in treatment due to genetic complexity and therapy resistance.
- Standard treatments like chemotherapy and stem cell transplantation (HSCT) have limitations, leaving many patients with unsatisfactory outcomes.
- Immunotherapy offers a promising avenue to enhance anti-leukemia responses by leveraging the patient's immune system.
Purpose of the Study:
- To review the role of Natural Killer (NK) cells in acute myeloid leukemia (AML) immune surveillance.
- To elucidate mechanisms of NK cell dysfunction in AML.
- To discuss current and future therapeutic strategies utilizing NK cells for AML management.
Main Methods:
- Review of existing literature on NK cell function in AML.
- Analysis of mechanisms underlying NK cell impairment in the context of AML.
- Examination of current and emerging NK cell-based immunotherapies for AML.
Main Results:
- NK cells possess inherent capabilities to eliminate AML cells directly.
- NK cell function is often compromised in patients with AML, hindering effective anti-leukemia immunity.
- Various strategies are being developed to enhance NK cell activity and overcome immune evasion in AML.
Conclusions:
- NK cell-based immunotherapies represent a significant potential advancement in AML treatment.
- Addressing NK cell dysfunction and immune escape is crucial for improving treatment efficacy and durability.
- Further research is vital to optimize NK cell therapies for personalized AML treatment approaches.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K